Lovisa Afzelius is the founder of Apriori Bio. A computational scientist by training, she has two decades of leadership experience in data-driven drug.
Lovisa Afzelius is the Co-founder & CEO of Apriori Bio and a General Partner at Flagship Pioneering. A computational scientist by training, she has two decades of leadership experience in data-driven drug discovery, serving in various executive roles in emerging biotech and large pharma companies. She has been recognized on Inc. Magazine's Female Founders 250 List (2024), PharmaVoice 100 list (2023), and as one of the Top Women in Biopharma by Endpoints (2022).
Full founder directory · Investor directory · Company funding database · Fundraising library